Characterizing Swallowing Abnormalities in Progressive Supranuclear Palsy
Neurol 48:1654-1662, Litvan,I.,et al, 1997
Clinicopath Conf
Progressive Supranuclear Palsy, Case 26, 1997, NEJM 337:549-55697., , 1997
A Gene for Parkinson Disease
Arch Neurol 54:1156-1157, Chase,T.N., 1997
Dietary Antioxidants and Parkinson Disease
Arch Neurol 54:762-765, deRijk,M.C.,et al, 1997
What is the Accuracy of the Clinical Diagnosis of Multiple System Atrophy
Arch Neurol 54:937-944, Litvan,I.,et al, 1997
Olfactory Dysfunction in Parkinson's Disease
JNNP 62:436-446, Hawkes,C.H.,et al, 1997
Neurological Signs and Frontal White Matter Lesions in Vascular Parkinsonism
Stroke 28:965-969, Yamanouchi,H.&Nagura,H., 1997
Distinction of Idiopathic Parkinson's Dis from Multi-Syst Atrophy by Stim of Growth-Hormone Release w Clonidine
Lancet 349:1877-1881, Kimber,J.R.,et al, 1997
Posteroventral Medial Pallidotomy in Levodopa-Unresponsive Parkinsonism
Arch Neurol 54:1026-1029, Krauss,J.K.,et al, 1997
Stereotactic Pallidotomy for Parkinson's Disease:A Long-Term Follow-up of Unilateral Pallidotomy
Neurol 48:1273-1277, Fazzini,E.,et al, 1997
Posteroventral Pallidotomy in a Patient with Parkinsonism Caused by Hypoxic Encephalopathy
Neurol 49:707-710, Goto,S.,et al, 1997
Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997
Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997
Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997
Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997
Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997
Managing the Late Complications of Parkinson's Disease
Neurol 49:549-557, Waters,C.H., 1997
Severe but Transient Parkinsonism after Tetanus Vaccination
JNNP 63:258, Reijneveld,J.C.,et al, 1997
Tolcapone in Stable Parkinson's Disease:Efficacy and Safety of Long-Term Treatment
Neurol 49:665-671, Waters,C.H.,et al, 1997
Unilateral Pallidotomy for Parkinson's Disease:Comparison of Outcome in Yonger Vs Elderly Patients
Neurol 49:1072-1077, Uitti,R.J.,et al, 1997
Clozapine in Parkinson's Disase Tremor, Effets of Acute and Chronic Administration
Neurol 49:1587-1590, Bonuccelli,U.,et al, 1997
Oral and Genital Pain Syndromes in Parkinson's Disease
Movement Disorders 11:421-426, Ford,B.,et al, 1996
Liquid Levodopa/Carbidopa Produces Significant Improvement in Motor Function without Dyskinesia Exacerbation
Neurol 47:1493-1495, Pappert,E.J.,et al, 1996
Presymptomatic Diagnosis of Neurofibromatosis 2 Using Linked Genetic Markers, Neuroimging, and Ocular Examinations
Neurol 47:1269-1277, Baser,M.E., 1996
Nonmotor Fluctuations in Patients with Parkinson's Disease
Neurol 47:1180-1183, Hillen,M.E.&Sage,J.I., 1996
Clinical and Pathological Features in Hydrocarbon-Induced Parkinsonism
Ann Neurol 40:922-925, Pezzoli,G.,et al, 1996
Visual Hallucinations Associated with Parkinson Disease
Arch Neurol 53:1265-1268, Sanchez-Ramos,J.R.,et al, 1996
Selegiline and Mortality in Parkinson's Disease
Ann Neurol 40:841-845, Olanow,C.W.,et al, 1996
A Gene for Parkinson's Disease
BMJ 313:1278, Hawkes,C., 1996
Clinical Genetic Analysis of Parkinson's Disease in the Contursi Kindred
Ann Neurol 40:767-775, Golbe,L.I.,et al, 1996
Neuropsychiatric Aspects of Progressive Supranuclear Palsy
Neurol 47:1184-1189, Litvan,I.,et al, 1996
Motor Neuron Disease with Parkinsonism
Arch Neurol 53:987-991, Qureshi,A.I.,et al, 1996
Neurotoxicity Related to the Use of Topical Tretinoin (Retin-A)
Ann Int Med 124:227-228, Bernstein,A.L.&Leventhal-Rochon,J.L., 1996
Living with Parkinson's Disease
NEJM 334:114-116, Salzman,E.W., 1996
Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
NEJM 334:71-76, Bennett,D.A.,et al, 1996
Consensus Guidelines for Clin & Path Dx of Dementia with Lewy Bodies (DLB) :Report of DLB Intl Workshop
Neurol 47:1113-1114, 11241996., McKeith,I.G.,et al, 1996
Isolated Vitamin E Deficiency
Muscle & Nerve 19:1161-1165996., Jackson,C.E.,et al, 1996
Total Alopecia, Diabetes Mellitus, and Falls
Lancet 348:1420, Mueller-Schoop,J.W., 1996
Clinicopath Conf
Q Fever, Acute (with Cerebellar and Meningeal Involvement) , Case 38-1996, NEJM 335:1829-1834., , 1996
Charcot-Marie-Tooth Disease and Related Inherited Neuropathies
Medicine 75:233-250, Murakami,T.,et al, 1996
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
NEJM 335:1169-1175, 12221996., Durr,A.,et al, 1996
An Emotional 13-Year Old Girl
Lancet 348:1000, Kanabar,D.J.,et al, 1996
A Man with Weight Loss, Ataxia, and Confusion for 3 Months
Lancet 347:448, Beversdorf,D.,et al, 1996
Bent Spine Syndrome
JNNP 60:51-54, Serratrice,G.,et al, 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996
Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996
Delayed Emergence of a Park Dis in 38% of 29 Older Men Initially Dx with Idiop REM Sleep Behavior Disorder
Neurol 46:388-393, Schenck,C.H.,et al, 1996
A 60-Year-Old Man with Parkinson's Disease
JAMA 275:716-722, Olanow,C.W., 1996
Lewy Body Disease and Dementia
Arch Int Med 156:487-493, Kalra,S.,et al, 1996
Motor Changes in Presymptomatic Huntington Disease Gene Carriers
Arch Neurol 53:487-492, Siemers,E.,et al, 1996